19
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3565 | VU0155041 | UV0155041,VU-0155041 | GluR |
VU0155041 is an effective and positive allosteric modulator/allosteric agonist at mGlu4 receptors (EC50: 798/693 nM, at human/rat). | |||
T4500 | ADX88178 | GluR | |
ADX88178 is a potent positive allosteric modulator for metabotropic glutamate receptor 4 (mGluR4) with EC50 of 4 nM for human mGluR4. | |||
T13424 | (1R,2S)-VU0155041 | GluR | |
(1R,2S)-VU0155041 is the cis regioisomer of VU0155041 and a partial agonist of mGluR4. | |||
T29135 | VU0422288 | VU-0422288,ML-396,ML396,VU 0422288,ML 396 | GluR |
VU0422288 (ML396) is a potent orthosteric modulator of type III mGlu receptors (mGlus).VU0422288 shows inhibition of mGluR4, mGluR7, and mGluR8 in a calcium mobilization assay.VU0422288 can be used to study Rett syndrome... | |||
T3464 | PHCCC | (-) PHCCC | GluR |
PHCCC ((-) PHCCC) is a Group I metabotropic glutamate receptor antagonist and a positive allosteric modulator of mGluR4. It also is a potent to antagonism for mGluR2 and mGluR8. | |||
T41301 | L-Cysteinesulfinic acid monohydrate | GluR | |
L-Cysteinesulfinic acid monohydrate is a potent agonist at rat metabotropic glutamate receptors (mGluRs) with pEC50s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectiv... | |||
T6726 | VU0361737 | ML-128,VU 0361737 | GluR |
VU0361737 (ML-128) is a specific positive allosteric modulator (PAM) of mGlu4 receptor.The EC50 of VU 0361737 is 240 nM for the human receptors. The EC50 of VU 0361737 is110 nM for rat receptors.It exhibits weak activity... | |||
T6160 | VU 0364439 | GluR | |
VU 0364439 is a mGlu4 positive allosteric modulator (C50: 19.8 nM). | |||
T29125 | VU0359516 | VU 0359516,VU-0359516 | |
VU0359516 is a mGluR4 positive allosteric modulators. | |||
T11311L | Foliglurax | PXT002331 | GluR |
Foliglurax is a highly selective brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) (EC50: 79 nM). | |||
T29121 | VU0080241 | VU-0080241,VU 0080241 | |
VU0080241 is a positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). | |||
T11311 | Foliglurax monohydrochloride | PXT002331 (monohydrochloride) | Others |
Foliglurax monohydrochloride Antiparkinsonian effect. is a highly selective and potent, brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) , with an EC50 of 79 nM. | |||
T29133 | VU0410150 | VU-0410150,VU 0410150 | |
VU0410150, a pyrrylarylsulfone containing compound, has been found to be a mGluR4-positive allosteric modulator and has been evaluated as a potential drug for the treatment of Parkinson’s disease. | |||
T11803 | L-Cysteinesulfinic acid | Others | |
L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs, pEC50s of 3.92±0.03, 4.6±0.2, 3.9±0.2, 2.7±0.2, 4.0±0.2, and 3.94±0.08 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and ... | |||
T3484 | Trans-ACPD | Trans-(±)-ACP,1-amino-1,3-dicarboxycyclopentane,(±)-trans-ACPD | GluR |
trans-ACPD ((±)-trans-ACPD) is an equimolecular mixture of (1S, 3R)- and (1R, 3S)-ACPD. trans-ACPD is a selective agonist of the mGluR (metabotropic glutamate receptor); active at the group I/II mGlu receptors (EC50: 2/1... | |||
T3486 | 3-MATIDA | GluR , NMDAR | |
3-MATIDA is an effective mGluR-1 antagonist (IC50: 6.3 μM, rat mGluR-1a). Displays ≥ 40-fold selectivity over other receptors: mGluR-5, mGluR-2, mGluR-4 (mGluR-4a) (IC50 > 300 μM), NMDA and GluR (AMPA) (IC50 = 250 μM). 3... | |||
T23515 | VU-29 | VU 29 | GluR |
VU-29 is a positive allosteric mGlu5 receptor modulator with EC50=9 nM and Ki=244 nM for rmGluR5. It is selective for mGluR5 relative to other mGluR subtypes (EC50: rmGluR1/rmGluR2=557 nM/1.5 μM; hmGluR4=154 nM). | |||
T23507 | VU0155041 sodium | VU 0155041 sodium salt | Others |
positive allosteric modulator/allosteric agonist of mGlu4 receptor | |||
T15456 | GYKI 53655 hydrochloride | GYKI53655 hydrochloride,LY300168 hydrochloride | GluR |
GYKI 53655 hydrochloride (LY300168 hydrochloride) is an antagonist of AMPA and is used in the study of neurological disorders. |